Sale of investment securities and expected recognition of extraordinary income
REGAL CORPORATION (filing company)
Part of the listed securities held by the Company
Sale in line with the policy of reducing policy-held shareholdings. The proceeds from the sale will be used to fund business-restructuring expenses and other costs associated with the dissolution of an overseas subsidiary.
Approximately ¥260 million (gain on sale of investment securities, expected to be recognized as extraordinary income in the fiscal year ending February 2027)
Fiscal year ending February 2027
For the impact of this matter on full-year results for the fiscal year ending February 2027, refer to the “Notice Regarding Revision of the Full-Year Earnings Forecast and Year-End Dividend Forecast and Continuation of Reductions in Executive Compensation” disclosed today.
Company response
Although this document does not provide details, the title of the referenced disclosure includes “Continuation of Reductions in Executive Compensation.”
The sale is scheduled to take place between 12 November 2026 and 28 February 2027. The gain on sale of investment securities is expected to be recognized as extraordinary income in the fiscal year ending February 2027. The gain on sale is an estimate and may change.
| Item | Details |
|---|---|
| Event name | Sale of investment securities and expected recognition of extraordinary income |
| Date of occurrence | 11 November 2026 (date of board resolution) |
| Subject Entity | REGAL CORPORATION (filing company) |
| Target Locations / Products | Part of the listed securities held by the Company |
| Cause | Sale in line with the policy of reducing policy-held shareholdings. The proceeds from the sale will be used to fund business-restructuring expenses and other costs associated with the dissolution of an overseas subsidiary. |
| Amount of Impact on Business Performance | Approximately ¥260 million (gain on sale of investment securities, expected to be recognized as extraordinary income in the fiscal year ending February 2027) |
| Accounting period in which recognized | Fiscal year ending February 2027 |
| Impact on Earnings Forecast | For the impact of this matter on full-year results for the fiscal year ending February 2027, refer to the “Notice Regarding Revision of the Full-Year Earnings Forecast and Year-End Dividend Forecast and Continuation of Reductions in Executive Compensation” disclosed today. |
| Directors' and officers' liability | Although this document does not provide details, the title of the referenced disclosure includes “Continuation of Reductions in Executive Compensation.” |
| Outlook | The sale is scheduled to take place between 12 November 2026 and 28 February 2027. The gain on sale of investment securities is expected to be recognized as extraordinary income in the fiscal year ending February 2027. The gain on sale is an estimate and may change. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The sale is in line with the policy of reducing policy-held shareholdings and is intended to fund business-restructuring expenses and other costs associated with the dissolution of an overseas subsidiary.